ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of DKK 10.43 billion. The enterprise value is 10.18 billion.

Market Cap	10.43B
Enterprise Value	10.18B

Important Dates

The last earnings date was Wednesday, February 5, 2025.

Earnings Date	Feb 5, 2025
Ex-Dividend Date	Oct 11, 2024

Share Statistics

ChemoMetec has 17.40 million shares outstanding. The number of shares has decreased by -0.13% in one year.

Current Share Class	n/a
Shares Outstanding	17.40M
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	52.69%
Float	17.34M

Valuation Ratios

The trailing PE ratio is 61.67 and the forward PE ratio is 49.21. ChemoMetec's PEG ratio is 4.56.

PE Ratio	61.67
Forward PE	49.21
PS Ratio	22.69
PB Ratio	17.45
P/TBV Ratio	22.45
P/FCF Ratio	68.56
P/OCF Ratio	n/a
PEG Ratio	4.56

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.26, with an EV/FCF ratio of 66.87.

EV / Earnings	60.18
EV / Sales	22.14
EV / EBITDA	46.26
EV / EBIT	48.38
EV / FCF	66.87

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.01.

Current Ratio	4.00
Quick Ratio	2.88
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	0.05
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 30.83% and return on invested capital (ROIC) is 23.68%.

Return on Equity (ROE)	30.83%
Return on Assets (ROA)	19.86%
Return on Invested Capital (ROIC)	23.68%
Return on Capital Employed (ROCE)	34.62%
Revenue Per Employee	2.50M
Profits Per Employee	918,918
Employee Count	174
Asset Turnover	0.69
Inventory Turnover	0.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.06% in the last 52 weeks. The beta is 1.30, so ChemoMetec's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	+36.06%
50-Day Moving Average	525.96
200-Day Moving Average	421.75
Relative Strength Index (RSI)	66.58
Average Volume (20 Days)	52,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of DKK 459.54 million and earned 169.08 million in profits. Earnings per share was 9.72.

Revenue	459.54M
Gross Profit	418.51M
Operating Income	210.34M
Pretax Income	220.40M
Net Income	169.08M
EBITDA	219.98M
EBIT	210.34M
Earnings Per Share (EPS)	9.72

Full Income Statement

Balance Sheet

The company has 264.74 million in cash and 7.78 million in debt, giving a net cash position of 256.96 million or 14.77 per share.

Cash & Cash Equivalents	264.74M
Total Debt	7.78M
Net Cash	256.96M
Net Cash Per Share	14.77
Equity (Book Value)	597.98M
Book Value Per Share	34.36
Working Capital	368.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 176.20 million and capital expenditures -24.04 million, giving a free cash flow of 152.17 million.

Operating Cash Flow	176.20M
Capital Expenditures	-24.04M
Free Cash Flow	152.17M
FCF Per Share	8.74

Full Cash Flow Statement

Margins

Gross margin is 91.07%, with operating and profit margins of 45.77% and 36.79%.

Gross Margin	91.07%
Operating Margin	45.77%
Pretax Margin	47.96%
Profit Margin	36.79%
EBITDA Margin	47.87%
EBIT Margin	45.77%
FCF Margin	33.11%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.66%.

Dividend Per Share	4.00
Dividend Yield	0.66%
Dividend Growth (YoY)	-33.33%
Years of Dividend Growth	n/a
Payout Ratio	41.16%
Buyback Yield	0.13%
Shareholder Yield	0.79%
Earnings Yield	1.62%
FCF Yield	1.46%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ChemoMetec has an Altman Z-Score of 34.57.

Altman Z-Score	34.57
Piotroski F-Score	n/a